Sign in

CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company

BioXcel Therapeutics, Inc.

Sign in to watch
Ticker
BTAIQ
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
821386754
Phone
203-643-8060
Business address
555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
  1. 4 Open-market sale Chief Scientific Officer sold 50,000 shares at $30.00 ($1,500,000)
  2. 4 Open-market sale Chief Medical Officer sold 29,713 shares at $30.00 ($891,390)
  3. 4 Open-market sale Director sold 60,000 shares at an average $22.01 ($1,320,876)
  4. 4 Open-market sale CEO and President sold 60,000 shares at an average $19.69 ($1,181,498)
  5. 8-K Event Other events
  6. 4 Open-market sale Director sold 60,000 shares at $15.00 ($900,000)
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 8-K Event Other events
  10. 8-K Event Executive or director change
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Other events
  15. 8-K Event Other events
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 8-K Event Executive or director change
  19. EFFECT Other Notice of Effectiveness
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 20 of 34 · 672 filings